(Q37891375)

24 August 2017

1 reference

title

Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases (English)

1 reference

24 August 2017

0 references

mesenchymal stem cell

1 reference

Antonio Uccelli

1

0 references

author name string

Alice Laroni

series ordinal

2

1 reference

PubMed ID

21683930

24 August 2017

Mark S Freedman

series ordinal

3

1 reference

24 August 2017

1 July 2011

1 reference

24 August 2017

1 reference

24 August 2017

10

1 reference

24 August 2017

7

1 reference

24 August 2017

649-656

1 reference

Remyelination in the CNS: from biology to therapy

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Regenerative medicine in multiple sclerosis: identifying pharmacological targets of adult neural stem cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Retinoid X receptor gamma signaling accelerates CNS remyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Human embryonic stem cells: an experimental and therapeutic resource for neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Europe rules against stem-cell patents

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Impact of induced pluripotent stem cells on the study of central nervous system disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Autologous haematopoietic stem-cell transplantation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Hematopoietic cells maintain hematopoietic fates upon entering the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: Clinical and biological results from a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

The therapeutic potential of neural stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Remyelination of the spinal cord following intravenous delivery of bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stem cells in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Bone marrow stromal cell therapy reduces proNGF and p75 expression in mice with experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Stem cell transplantation in multiple sclerosis: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Defeating stem cell tourism. Foreword

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Stem cell treatment in Amyotrophic Lateral Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Autologous mesenchymal stem cell transplantation in stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stem cell homing: the devil is in the details

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Defining the risks of mesenchymal stromal cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970121-1

7 January 2021

10.1016/S1474-4422(11)70121-1

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fgrm6ymbmfd4xbzykfsogjxkge

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_fgrm6ymbmfd4xbzykfsogjxkge

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fgrm6ymbmfd4xbzykfsogjxkge

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/fgrm6ymbmfd4xbzykfsogjxkge

30 July 2022